Yanqing Zhou

Pharmacokinetics and tissue distribution of Ebracteolatain A, a potential anti‐cancer compound, as determined by an optimized ultra‐performance liquid chromatography tandem mass spectrometry method

Liang Zhao, Yang Jiao, Yue Liu, 2019, Journal of pharmaceutical and biomedical analysis.

Human liver microsomes study on the inhibitory effect of plantainoside D on the activity of cytochrome P450 activity

Jin Zhou, Ying Wang, Ping-Ping Zhao, 2022, BMC Complementary Medicine and Therapies.

Ebracteolatain A exerts anti-proliferation of breast cancer by inhibiting Protein kinase D 1 in MEK/ERK and PI3K/AKT signaling pathways.

Liang Zhao, Chengjian Li, Yamei Li, 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Multitarget and Multipathway Regulation of Zhenqi Fuzheng Granule against Non-Small Cell Lung Cancer Based On Network Pharmacology and Molecular Docking

Liang Zhao, Yang Jiao, Chengjian Li, 2022, Evidence-based complementary and alternative medicine : eCAM.

In vitro study on the effect of cornin on the activity of cytochrome P450 enzymes

Zengqiang Qu, Yanqing Zhou, Jin Zhou, 2021, BMC Complementary Medicine and Therapies.

Agrimoniin inhibits the activity of CYP1A2, 2D6, and 3A4 in human liver microsomes

Haimin Wei, Yamei Li, Qian Xian, 2021, Xenobiotica; the fate of foreign compounds in biological systems.